Investigating feasibility of 2021 WHO protocol for cervical cancer screening in underscreened populations: PREvention and SCReening Innovation Project Toward Elimination of Cervical Cancer (PRESCRIP-TEC)

BACKGROUND: High-risk human papillomavirus (hrHPV) testing has been recommended by the World Health Organization as the primary screening test in cervical screening programs. The option of self-sampling for this screening method can potentially increase women’s participation. Designing screening pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Sultanov, Marat, Zeeuw, Janine de, Koot, Jaap, der Schans, Jurjen van, Beltman, Jogchum J., Fouw, Marlieke de, Majdan, Marek, Rusnak, Martin, Nazrul, Naheed, Rahman, Aminur, Nakisige, Carolyn, Rao, Arathi P., Prasad, Keerthana, Guruvare, Shyamala, Biesma, Regien, Versluis, Marco, de Bock, Geertruida H., Stekelenburg, Jelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284962/
https://www.ncbi.nlm.nih.gov/pubmed/35840949
http://dx.doi.org/10.1186/s12889-022-13488-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284962/
https://www.ncbi.nlm.nih.gov/pubmed/35840949
http://dx.doi.org/10.1186/s12889-022-13488-z

Ejemplares similares